Pricing Log in Create free account

China Pharma Holdings, Inc. (CPHI) vs Universe Pharmaceuticals INC (UPC)

China Pharma Holdings, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. is the larger, with a market value of $31.3M against $20.9M — 1.5× the size. Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −114.3%) and the higher return on invested capital (0.00% vs −7.23%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 13 and China Pharma Holdings, Inc. on 2.

Valuation

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 7.35 n/m 2.11
P/B 0.80 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 8.52 12.58
EV/Sales 8.11 (0.24) 2.73
Earnings yield (60.56%) (36.78%) (4.38%)
Free cash flow yield (1.16%) 0.00% 0.00%

Profitability

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
Gross margin 11.76% 49.77% 53.94%
Operating margin (111.84%) 0.00% 0.00%
Net margin (114.33%) (6.42%) 0.00%
Free cash flow margin (3.59%) 0.00% 0.00%
Return on equity (20.99%) 0.00% (0.40%)
Return on assets (15.30%) 0.00% (3.32%)
Return on invested capital (7.23%) 0.00% 0.00%

Growth

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.97%) — 10.01%
EPS growth (last fiscal year) 72.59% 98.71% 49.06%
Revenue growth, 5-year CAGR (17.53%) (10.27%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.17 0.05
Current ratio 0.26 4.05 2.31
Net debt to EBITDA (0.98) 10.15 0.97

Dividend

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CPHI UPC Drug Manufacturers Specialty & Generic median
Market cap 31.32m 20.85m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack